RCKT
Rocket Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$323.21M
P/E Ratio
—
EPS
$-1.87
Beta
0.52
52W High
$5.45
52W Low
$2.19
50-Day MA
$3.73
200-Day MA
$3.57
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company is headquartered in Cranbury, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-202.46M |
| Operating Margin | 0.00% |
| Return on Equity | -64.40% |
| Return on Assets | -35.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.18 |
| Price-to-Book | 1.36 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $109.19M |
| Float | $87.64M |
| % Insiders | 2.95% |
| % Institutions | 89.87% |
Historical Volatility
HV 10-Day
58.41%
HV 20-Day
59.49%
HV 30-Day
59.38%
HV 60-Day
83.41%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($9.30 target)
6
Buy6
Hold1
Sell1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026